IMPURITY-3;1-[[[(1-R)-1-[3-[(1-E)-2-(7-CHLORO-2-QUINOLINYL)-ETHYL]-PHENYL-3-[2-(1-HYDROXY-1-METHYLETHYL)-PHENYL]-PROPYL
Compound with spectra: 1 NMR
![IMPURITY-3;1-[[[(1-R)-1-[3-[(1-E)-2-(7-CHLORO-2-QUINOLINYL)-ETHYL]-PHENYL-3-[2-(1-HYDROXY-1-METHYLETHYL)-PHENYL]-PROPYL](/api/compound/nBUGECYHMQ.png?ph=true&h=300&w=458 "IMPURITY-3;1-[[[(1-R)-1-[3-[(1-E)-2-(7-CHLORO-2-QUINOLINYL)-ETHYL]-PHENYL-3-[2-(1-HYDROXY-1-METHYLETHYL)-PHENYL]-PROPYL")
| SpectraBase Compound ID | nBUGECYHMQ |
|---|---|
| InChI | InChI=1S/C35H38ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-9,11-12,14,16,20-21,32,40H,10,13,15,17-19,22-23H2,1-2H3,(H,38,39)/t32-/m0/s1 |
| InChIKey | QYOIIAUGMZLCEO-YTTGMZPUSA-N |
| Mol Weight | 588.2 g/mol |
| Molecular Formula | C35H38ClNO3S |
| Exact Mass | 587.226093 g/mol |
| Enantiomer InChIKey | QYOIIAUGMZLCEO-JGCGQSQUSA-N |
| Racemate InChIKey | QYOIIAUGMZLCEO-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
Montelukast sodium hydrate
IMPURITY-1;1-[[[(1-R)-1-[3-[(1-E)-2-(7-CHLORO-2-QUINOLINYL)-ETHENYL]-PHENYL-3-[2-(1-HYDROXY-1-METHYLETHYL)-PHENYL]-PROPYL]-THI
IMPURITY-2;{1-[1-{3-[2-(7-CHLORO-QUINOLIN-2-YL)-VINYL]-PHENYL}-3-(2-ISOPROPENYL-PHENYL)
Bis(1,3-dioxoindene-2-yl)(2-quinolinyl)methane
N'-((E)-{2-[(4-bromobenzyl)oxy]phenyl}methylidene)-2-cyclopropyl-4-quinolinecarbohydrazide
Ethyl 6-Chloro-1-phenylindole-2-carboxylate
7-METHOXY-BETA-CARBOLINE-1-PROPIONIC-ACID
(10R)-10-methyl-8,9,10,11-tetrahydrobenzo[b][1,10]phenanthroline
9-Methyl-3,4-dihydro-2H-acridin-1-one
9-Amino-6-methoxy-1,2,3,4-tetrahydroacridine
| Title | Journal or Book | Year |
|---|---|---|
| Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodium | Journal of Pharmaceutical and Biomedical Analysis | 2008 |